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Summary
an 80-year-old man presented repeatedly to his general 
practitioner with 3 months of unexplained persistent 
frontal headaches. Ct head revealed no diagnosis. His 
dentist diagnosed his co-existing jaw pain as bruxism. 
three months later, the patient happened to attend 
a routine ophthalmology follow-up appointment. 
During this routine appointment, features of giant cell 
arteritis (GCa) including worrying visual complications 
were first noted. His inflammatory markers (C-reactive 
protein and erythrocyte sedimentation rate) were not 
significantly raised—contrary to the norm. a temporal 
artery ultrasound and biopsy were performed, in light 
of the history. this confirmed GCa. He was commenced 
on high-dose oral prednisolone and was managed 
by ophthalmology and rheumatology. at 4 weeks, 
symptoms resolved with no permanent visual loss 
despite a prolonged initial symptomatic period. Multiple 
symptomatic presentations to different specialties 
should therefore alert clinicians to a unifying diagnosis, 
for example, vasculitis. serious illnesses may present 
with severe symptoms despite normal screening 
investigations.
BaCkground 
This case provides a warning on how easily 
common presentations may be dismissed, and 
serious diagnoses delayed if a broad list of differ-
entials including additional systemic involvement is 
not considered.
This case illustrates how unexplained persistent 
headaches should raise the index of suspicion of 
atypical causes such as vasculitis. A judgement on 
the likelihood of vasculitis can be made at the time 
of clinical review with focused questions. This 
patient visited three different health professionals 
before a correct diagnosis was reached. Piecing 
together different symptoms and a patient timeline 
could have led to an earlier diagnosis. Asking ‘red 
flag’ questions is paramount in ensuring serious 
conditions are not missed. This is particularly 
important in systemic diseases, as patients are not 
necessarily aware of which symptoms are relevant. 
Thus, they may not volunteer the relevant clin-
ical information unless prompted. This last point 
enabled the ophthalmologist to consider giant cell 
arteritis (GCA) as a diagnosis.
We demonstrate that although investigation 
results may be characteristic, they cannot always be 
relied on to exclude systemic diseases. In this case, 
inflammatory markers were not significantly raised, 
an unusual but well-documented occurrence. This 
is supported by a study that identified 167 patients 
fulfilling the American College of Rheumatology 
criteria for GCA over a 48-year period. Of these 
patients, nine had a reported erythrocyte sedimen-
tation rate (ESR) of less than 40 mm/hour. Six of 
the nine patients had an ESR of <30 mm/hour. 
All nine of these patients had a positive temporal 
artery biopsy.1 History taking and clinical judgement 
should therefore always take precedence in forming 
a diagnosis, and diagnoses not to be ruled out on 
the basis of normal tests; an important message in 
today’s investigation-driven medical practice.
In the case of GCA, important screening ques-
tions to consider should include: scalp tenderness, 
temporal headaches, jaw claudication, visual distur-
bances, polymyalgia and constitutional symptoms.
CaSe preSenTaTion
An 80-year-old man with a medical history of glau-
coma, hypertension and first degree heart block 
presented with a 3-month history of frontal head-
aches. A routine CT head was requested by his 
general practitioner (GP). This showed no intracra-
nial masses or bony lesions but incidentally revealed 
a mature lacunar infarct of the left ventral thalamus. 
There was no radiographic cause determined for his 
headaches.
Alongside his headaches, the patient devel-
oped bilateral jaw pain with claudication. He 
independently sought advice from his dentist and 
returned with a diagnosis of bruxism.
Three days after the CT scan (3 months after 
initial presentation to healthcare), the patient visited 
ophthalmology for a routine glaucoma follow-up 
appointment. The ophthalmologist elicited episodes 
of diplopia, amaurosis fugax and significant weight 
loss in the preceding months. There was no history 
of scalp tenderness, fever or proximal muscle pain 
and stiffness. Examination revealed bilateral tender, 
nodular and weakly pulsatile temporal arteries. 
There was no relative afferent pupillary defect or 
anterior ischaemic optic neuropathy.
In light of the ongoing headaches, jaw claudica-
tion, diplopia, amaurosis fugax and weight loss, a 
diagnosis of GCA was suspected. The patient was 
referred the same day to the rheumatology depart-
ment for prompt review.
inveSTigaTionS
Inflammatory markers were not significantly 
raised: C-reactive protein (CRP) 11 mg/L (<10) 
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and ESR 15 mm/hour (1–19). Recognising that normal inflam-
matory markers do not rule out GCA, rheumatologists arranged 
urgent investigation. Temporal and axillary artery ultrasound 
(US) demonstrated a characteristic positive halo sign in the 
right temporal artery (figure 1). A right temporal artery biopsy 
(TAB) revealed a muscular artery with focal adventitial chronic 
inflammation and intimal hyperplasia with mild inflammation 
(figure 2), consistent with GCA.
differenTial diagnoSiS
Key differentials2:
‘Primary’ headaches
 ► Migraine.
 ► Tension type.
 ► Cluster.
‘Dangerous’ headaches
 ► Intracranial haemorrhage.
 ► Masses (benign or malignant).
 ► Metastases.
Referred pain
 ► Temporomandibular joint dysfunction.
 ► Dental abscess.
 ► Cervical spondylosis.
 ► Otalgia.
 ► Trigeminal neuralgia.
Vision related
 ► Transient ischaemic attack.
 ► Glaucoma.
TreaTmenT
Steroid treatment should be commenced immediately once a 
diagnosis of GCA is suspected, while awaiting further investiga-
tions. Sixty milligrams of prednisolone was initiated due to the 
presence of jaw claudication and visual symptoms in accordance 
with the British Society of Rheumatology guidelines.3 He was 
co-prescribed lansoprazole and alendronate for gastroprotec-
tion/bone protection and counselled regarding long-term steroid 
management and safety.
ouTCome and follow-up
At 4-week follow-up, his symptoms improved significantly and 
inflammatory markers remained low (CRP <3, ESR 2). Oral 
prednisolone was tapered down gradually with frequent review 
of intraocular pressures to exclude glucocorticoid-induced exac-
erbation of glaucoma. Subsequent follow-ups confirmed inactive 
GCA disease, with no episodes of relapse.
diSCuSSion
GCA was first described histologically by Bayard Horton.4 It 
is the most common of all vasculitides with a predilection for 
medium to large vessels in patients aged >50 years. The esti-
mated incidence of GCA is 1 per 10 000 person-years based on 
specific selection criteria.5 Inflammation of vessel walls causes 
reduced patency of the vessel lumen resulting in end tissue isch-
aemia and subsequent symptoms.6
Headaches are a common symptom and may have many 
plausible causes. A prospective study examined 262 patients, 
aged ≥65  years with  headache  from  primary  care,  neurology 
clinics and hospital inpatient referrals. From this, 362 headache 
episodes were coded and outcomes classified against the Inter-
national Classification of Headaches Disorders second Edition.7 
Primary headaches accounted for 62.2% of cases, most often 
tension type and migraine. GCA was responsible for only two 
headache cases.8
Although the overall incidence of GCA in patients presenting 
with headaches is very low, clinicians should consider it as an 
important differential in those where the presentation is atypical 
and not responding to conventional investigation or treatment. 
The diagnosis of suspected GCA is largely clinical. However, 
as with other vasculitides, multiorgan symptoms may prompt 
multiple presentations to GPs and other specialities including 
dentists, ophthalmologists, ENT and stroke services. Pattern 
recognition of key signs and symptoms is therefore vital for 
prompt investigation and treatment.
Key factors that have a high likelihood ratio (LR) of biopsy 
proven GCA include: the presence of jaw claudication (LR 4.2), 
diplopia (LR 3.4) and temporal artery beading, prominence or 
tenderness (LR 4.6, 4.3, 2.6, respectively).9 Thus, these should 
be sought for in clinical history and examination among other 
classical features, for example, aged ≥50 years, scalp tenderness, 
systemic symptoms and polymyalgia.3
Jaw claudication predicts the likelihood of developing perma-
nent visual loss.9 10 The combination of headache and jaw pain 
should always raise suspicion of GCA. Reassuringly, the inci-
dence of visual symptoms and complications in patients with 
figure 1 Craniofacial soft tissue ultrasound. Halo sign of right 
temporal artery indicative of giant cell arteritis. Arrow indicates vessel 
wall.
figure 2 Right temporal artery biopsy. Mild lymphocytic infiltrate in 
media and around vasa vasora and intimal thickening of right temporal 
artery.
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GCA has reduced in the last 50 years, and this may be in part 
due to greater clinician awareness, improved diagnostic methods 
and recognition of the need for prompt treatment.11
Classically, ESR is a diagnostic indicator for GCA and a 
normal ESR reduces the likelihood of biopsy positive GCA.9 
However, as in this case, elevated inflammatory markers may 
not always be present. Other cases report similar findings, with 
one case of a 73 year old with GCA, in whom ESR was only 
mildly elevated at 27 mm/hour.12 Similarly, a 74 year old with 
right-sided temporal headaches and initially normal inflamma-
tory markers (CRP <5 mg/L), re-presented 6 months later with 
scalp tenderness, jaw claudication and biopsy proven GCA.13 
Another elderly woman who presented with headaches, visual 
symptoms and jaw claudication was found to have normal 
ESR and CRP on repeated occasions. Despite this, US and 
biopsy assessment revealed GCA.14 Rana et al also reported 
a case of delayed diagnosis of GCA. An 81-year-old woman 
was presented with chronic headaches and an unremarkable 
CT head. Subsequently, she also presented to ophthalmology 
with a history of jaw claudication and irreversible visual 
symptoms.15
In our case, despite normal inflammatory markers, both TAB 
and temporal artery US were positive. The use of temporal 
artery US as an alternative to TAB has been examined in a large 
prospective multicentre study. This study (n=381) showed that 
the sensitivity for TAB was 39% with 100% specificity where 
clinical diagnosis was the reference standard. In comparison, 
temporal artery US had a sensitivity of 54% but a lower spec-
ificity of 81%. In addition, performing TAB on only those with 
negative temporal artery US would increase the sensitivity to 
65% with 81% specificity. This would potentially reduce the 
need for TAB by 43%.16 Our case highlights the need for referral 
to secondary care for investigations as above, in order to elicit 
positive findings in those with atypical features.
In summary, we present an unusual, but important case of 
delayed GCA diagnosis. The normal inflammatory markers at 
initial presentation led to a lower index of suspicion that GCA 
was a possible differential diagnosis. We suggest not dismissing 
GCA as a differential based on normal inflammatory markers, 
but to explore atypical presentations and in particular seek the 
presence of key symptoms. Education regarding clinical presen-
tations and advancements in imaging can help improve the 
recognition of atypical GCA presentations such as in this case.
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learning points
 ► Delayed diagnosis and treatment of giant cell arteritis (GCA) 
may lead to permanent visual loss.
 ► Suspect underlying systemic diseases, for example, vasculitis 
in patients presenting with persistently unexplained 
symptoms or multiple presentations.
 ► Confirm the presence (or absence) of red flags such as jaw 
claudication, visual disturbance and scalp tenderness in 
patients with headaches, to avoid missed opportunities in 
timely diagnosis.
 ► Normal or low-normal inflammatory markers do not exclude 
GCA; specialist review is required if red flag symptoms are 
present.
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